FMP

FMP

Enter

MNMD - Mind Medicine (...

photo-url-https://financialmodelingprep.com/image-stock/MNMD.png

Mind Medicine (MindMed) Inc.

MNMD

NASDAQ

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

5.41 USD

0.24 (4.44%)

About

ceo

Mr. Robert Barrow

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

CIK

0001813814

ISIN

CA60255C8850

CUSIP

60255C109

Address

1055 West Hastings Street

Phone

650 208 2454

Country

CA

Employee

57

IPO Date

Nov 15, 2016

MNMD Financial Summary

CIK

0001813814

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

60255C109

ISIN

CA60255C8850

Country

CA

Price

5.41

Beta

2.36

Volume Avg.

864.87k

Market Cap

440.16M

Shares

-

52-Week

2.41-12.22

DCF

2.19

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-2.65

P/B

-

Website

https://www.mindmed.co

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest MNMD News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep